# Tarsus Pharmaceuticals Inc. (TARS) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $451M |
| 2024 | $183M |
| 2023 | $17M |
| 2022 | $26M |
| 2021 | $57M |
| 2020 | — |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | $162M |
| 2025-09-30 | $119M |
| 2025-06-30 | $103M |
| 2025-03-31 | $78M |
| 2024-09-30 | $48M |
| 2024-06-30 | $41M |
| 2024-03-31 | $28M |
| 2023-09-30 | $2M |
| 2023-06-30 | — |
| 2023-03-31 | $3M |
| 2022-09-30 | — |
| 2022-06-30 | $15M |
| 2022-03-31 | $539,000 |
| 2021-09-30 | $1M |
| 2021-06-30 | $22M |
| 2021-03-31 | $33M |
| 2020-09-30 | — |
| 2020-06-30 | — |
| 2020-03-31 | — |

Source: [MarketCapTrends](https://marketcaptrends.com/company/TARS/revenue)
